Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: Visual outcome in relation to age at treatment-Reference-Cited by-同舟云学术

Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: Visual outcome in relation to age at treatment

Published:2004-10 Issue:4 Volume:138 Page:602-607
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Axer-Siegel Ruth,Ehrlich Rita,Weinberger Dov,Rosenblatt Irit,Shani Ludmila,Yassur Yuval,Priel Ethan,Kramer Michal

Publisher

Elsevier BV

Subject

Ophthalmology

Reference24 articles.

1. Photodynamic therapy of subfoveal chroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial— VIP Report No. 1;Ophthalmology,2001

2. Verteporfin therapy of subfoveal chroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial—VIP Report No. 3;Ophthalmology,2003

3. Pathologic findings in pathologic myopia;Grossniklaus;Retina,1992

4. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP Report 1;Arch Ophthalmol,1999

5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials—TAP Report 2;Arch Ophthalmol,2001

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choroidal Neovascularization;Pathologic Myopia;2021

2. Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age;Clinical Ophthalmology;2017-06

3. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration;International Journal of Molecular Sciences;2015-08-20

4. The other CNVM: A review of myopic choroidal neovascularization treatment in the age of anti-vascular endothelial growth factor agents;Survey of Ophthalmology;2015-05

5. Management of Choroidal Neovascularization Secondary to Pathological Myopia;Asia-Pacific Journal of Ophthalmology;2014